BMC’s response to the COVID-19 pandemic
As a publisher whose portfolio covers most biomedical and health disciplines, many of our researchers are on the front lines of understanding and responding to the COVID-19 pandemic and its aftermath. We are here for you. Find out about the ways BMC supports the research community during this time.
New Blog Series: “Research in the time of a pandemic”
As part of the new blog series ‘Research in the time of a pandemic’, we are talking to researchers and other key stakeholders involved in the battle against COVID-19. Read our interview with Dr. Emmanouil Dermitzakis, Director of the Health 2030 Genome Center in Switzerland and a key figure in a new epidemiological research project about SARS-CoV-2.
BMC Medical Research Methodology collection on research methodology for COVID-19
This BMC Medical Research Methodology collection aims to report on original peer-reviewed research articles in methodological approaches to medical research related to COVID-19. This follows a call from the WHO to immediately assess available data to learn what care approaches are most effective and evaluate the effects of therapies. Read more and find out how to submit.
The first COVID-19 trial protocols published in Trials
Given the speed at which clinical trials related to COVID-19 are being initiated, Jonathan Collin and Eleanor Cox have been working with the editors of Trials to ensure there is a simple and quick way for handling COVID-19 trial protocols. The first of these was published in Trials this month and several more have been submitted. Find out more.
Nature Briefing: Get a daily update on COVID-19, plus a selection of the most important non-coronavirus science news and insight.
Nature Briefing tracks down the best science journalism — from breaking news to fresh perspectives you may have missed. The newsletter provides a free daily update on COVID-19, plus a selection of the most important non-coronavirus science news and insight. Sign up and receive a free update in your inbox every weekday.
More relevant blogs and editorials on COVID-19
Can an effective SARS-CoV-2 vaccine be developed for the older population?
The challenge of misinformation during disease outbreaks
COVID-19: losing battles or winning the war?